Ilia I. Ouspenski

Array ( [id] => 8689756 [patent_doc_number] => 08389282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes' [patent_app_type] => utility [patent_app_number] => 12/593751 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 8 [patent_no_of_words] => 17428 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689756 [patent_doc_number] => 08389282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes' [patent_app_type] => utility [patent_app_number] => 12/593751 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 8 [patent_no_of_words] => 17428 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689756 [patent_doc_number] => 08389282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes' [patent_app_type] => utility [patent_app_number] => 12/593751 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 8 [patent_no_of_words] => 17428 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689756 [patent_doc_number] => 08389282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes' [patent_app_type] => utility [patent_app_number] => 12/593751 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 8 [patent_no_of_words] => 17428 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12593751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272474 [patent_doc_number] => 20090076250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Substance that Specifically Recognizes PD-1' [patent_app_type] => utility [patent_app_number] => 12/057637 [patent_app_country] => US [patent_app_date] => 2008-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11040 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20090076250.pdf [firstpage_image] =>[orig_patent_app_number] => 12057637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859117 [patent_doc_number] => 20080267967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'MODULATION OF CD200 RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/056561 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 41343 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267967.pdf [firstpage_image] =>[orig_patent_app_number] => 12056561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4948987 [patent_doc_number] => 20080305113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Pharmaceutical Composition for Preventing or Treating Chronic Graft-Versus-Disease Comprising Anti-CD137 Monoclonal Antibody' [patent_app_type] => utility [patent_app_number] => 12/048456 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4041 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20080305113.pdf [firstpage_image] =>[orig_patent_app_number] => 12048456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8385678 [patent_doc_number] => 08263070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Methods of modulating CD200 receptors' [patent_app_type] => utility [patent_app_number] => 12/045153 [patent_app_country] => US [patent_app_date] => 2008-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12052 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12045153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872733 [patent_doc_number] => 20080199467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Immunoglobulin fusion proteins and methods of making' [patent_app_type] => utility [patent_app_number] => 12/069499 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 30306 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199467.pdf [firstpage_image] =>[orig_patent_app_number] => 12069499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13955 [patent_doc_number] => 07807786 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'BSL2v1c2 polypeptides' [patent_app_type] => utility [patent_app_number] => 12/069064 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 62 [patent_no_of_words] => 76292 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807786.pdf [firstpage_image] =>[orig_patent_app_number] => 12069064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698832 [patent_doc_number] => 20080221016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'CD25+ DIFFERENTIAL MARKERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/023470 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 49839 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221016.pdf [firstpage_image] =>[orig_patent_app_number] => 12023470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4514465 [patent_doc_number] => 07932045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Method of isolating and proliferating autologous antigen-specific CD8+ T cell using anti-4-1BB antibodies' [patent_app_type] => utility [patent_app_number] => 12/010048 [patent_app_country] => US [patent_app_date] => 2008-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 6430 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932045.pdf [firstpage_image] =>[orig_patent_app_number] => 12010048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6062169 [patent_doc_number] => 20110200601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Drug Delivery to Human Tissues by Single Chain Variable Region Antibody Fragments Cloned by Phage Display' [patent_app_type] => utility [patent_app_number] => 12/522526 [patent_app_country] => US [patent_app_date] => 2008-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 27153 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200601.pdf [firstpage_image] =>[orig_patent_app_number] => 12522526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726694 [patent_doc_number] => 20080206235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/965611 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19888 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206235.pdf [firstpage_image] =>[orig_patent_app_number] => 11965611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751963 [patent_doc_number] => 20080160036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION AND AUTO-IMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 11/965425 [patent_app_country] => US [patent_app_date] => 2007-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18853 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160036.pdf [firstpage_image] =>[orig_patent_app_number] => 11965425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8801913 [patent_doc_number] => 08440185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Compositions and methods for the treatment of immunologic disorders' [patent_app_type] => utility [patent_app_number] => 11/964599 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 22616 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11964599 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4882321 [patent_doc_number] => 20080155704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Methods and Compositions for Determining in vivo Activity of BiP' [patent_app_type] => utility [patent_app_number] => 11/962459 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20080155704.pdf [firstpage_image] =>[orig_patent_app_number] => 11962459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8270509 [patent_doc_number] => 08212008 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Antibodies to CD200R' [patent_app_type] => utility [patent_app_number] => 12/520033 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 25090 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251920 [patent_doc_number] => 20100028341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/448260 [patent_app_country] => US [patent_app_date] => 2007-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 157297 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028341.pdf [firstpage_image] =>[orig_patent_app_number] => 12448260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676611 [patent_doc_number] => 08815519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Method for predicting cancer and other diseases' [patent_app_type] => utility [patent_app_number] => 12/520718 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 29357 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520718 [rel_patent_id] =>[rel_patent_doc_number] =>)